Title : Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine.

Pub. Date : 2013 Oct 4

PMID : 24133375






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Spironolactone was first developed over 50 years ago as a potent mineralocorticoid receptor (MR) antagonist with undesirable side effects; it was followed a decade ago by eplerenone, which is less potent but much more MR-specific. Eplerenone nuclear receptor subfamily 3 group C member 2 Homo sapiens